Scilex Holding (SCLX) Total Current Liabilities (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Total Current Liabilities of $501.8 million for Q1 2026, up 81.96% year-over-year from $275.7 million in Q1 2025, and up 3.74% on a QoQ basis from $483.7 million in Q4 2025.

Scilex Holding (SCLX) Total Current Liabilities (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Total Current Liabilities for 7 consecutive years, with $501.8 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Total Current Liabilities rose 81.96% year-over-year to $501.8 million; the TTM figure through Mar 2026 stood at $501.8 million (up 81.96% YoY), while the FY2025 annual figure was $483.7 million, up 86.28% from the prior year.
  • Total Current Liabilities came in at $501.8 million for Q1 2026 at Scilex Holding, up from $483.7 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $501.8 million in Q1 2026, with the low at $41003.0 in Q1 2022.
  • Average Total Current Liabilities over 5 years is $215.8 million, with a median of $252.7 million recorded in 2024.
  • Across the five-year window, Total Current Liabilities tumbled 73.53% in 2022 and surged 157454.33% in 2023, its largest moves.
  • Year by year, Total Current Liabilities stood at $44.8 million in 2022, then jumped by 458.36% to $250.4 million in 2023, then rose by 3.7% to $259.6 million in 2024, then soared by 86.28% to $483.7 million in 2025, then climbed by 3.74% to $501.8 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $501.8 million, $483.7 million, and $358.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 36.63 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 57.72 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 42.10 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -32.57 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 26.95 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 24.96 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 9.48 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 34.35 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 501.75 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 501.75 Mn
Dec 31, 2025 483.65 Mn
Sep 30, 2025 358.95 Mn
Jun 30, 2025 305.93 Mn
Mar 31, 2025 275.74 Mn
Dec 31, 2024 259.64 Mn
Sep 30, 2024 281.54 Mn
Jun 30, 2024 255.45 Mn
Mar 31, 2024 252.73 Mn
Dec 31, 2023 250.38 Mn
Sep 30, 2023 228.58 Mn
Jun 30, 2023 103.58 Mn
Mar 31, 2023 64.60 Mn
Dec 31, 2022 44.84 Mn
Sep 30, 2022 809,292.00
Jun 30, 2022 598,646.00
Mar 31, 2022 41,003.00
Dec 31, 2021 169.42 Mn
Sep 30, 2021 43,569.00
Jun 30, 2021 20,025.00